Drug Information

Drug General Information
Drug ID
D0P1HZ
Former ID
DNC000415
Drug Name
CHAP1
Drug Type
Small molecular drug
Indication Cancer [ICD9: 140-229; ICD10:C00-C96] Investigative [535274], [536509]
Structure
Download
2D MOL

3D MOL
Formula
C31H39N5O6
Canonical SMILES
C1CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2C1)CC3=CC=CC=C3)CC4<br />=CC=CC=C4)CCCCCC(=O)NO
InChI
1S/C31H39N5O6/c37-27(35-42)17-9-3-8-15-23-28(38)33-24(19-21-11-4-1-5-12-21)29(39)34-25(20-22-13-6-2-7-14-22)31(41)36-18-10-16-26(36)30(40)32-23/h1-2,4-7,11-14,23-26,42H,3,8-10,15-20H2,(H,32,40)(H,33,38)(H,34,39)(H,35,37)/t23-,24-,25-,26+/m0/s1
InChIKey
FQWUNUXAOHTLLG-ASDGIDEWSA-N
PubChem Compound ID
6917986
PubChem Substance ID
12013942, 14788869, 17194637, 43529388, 57371759, 78028517, 103314270, 104012356, 114787260, 142077365, 247422143
Target and Pathway
Target(s) Histone deacetylase Target Info Inhibitor [535274], [536509]
References
Ref 535274Histone deacetylase as a new target for cancer chemotherapy. Cancer Chemother Pharmacol. 2001 Aug;48 Suppl 1:S20-6.
Ref 536509Histone deacetylase inhibitors in cancer therapy: latest developments, trends and medicinal chemistry perspective. Anticancer Agents Med Chem. 2007 Sep;7(5):576-92.
Ref 535274Histone deacetylase as a new target for cancer chemotherapy. Cancer Chemother Pharmacol. 2001 Aug;48 Suppl 1:S20-6.
Ref 536509Histone deacetylase inhibitors in cancer therapy: latest developments, trends and medicinal chemistry perspective. Anticancer Agents Med Chem. 2007 Sep;7(5):576-92.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.